Follow The Filings

ELAN Elanco Animal Health

Elanco Animal Health earnings company data as of 7:06 PM ET 10/30

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 6 Nov EPS 0.20 — —
Rev $1.21B — —

Insider trades

Open-market buys and sales by ELAN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ELAN insider trades
  • $2.6M bought by 7 insiders
  • None no sales outside a trading plan
  • $100K sold by 1 insider under 10b5-1 plans
  1. Timothy J Bettington See Remarks
    Planned sale
    $100K 4,350 shares at $23.00 3% of stake
    Traded Oct 15 Filed Oct 19
    ↗
  2. Lawrence Erik Kurzius Director
    Buy
    $936K 40,000 shares at $23.40 +27% to stake
    Traded Aug 20 Filed Aug 21
    ↗
  3. Shiv O'Neill Gc and Corp Sec
    Buy
    $94K 3,998 shares at $23.58 +4.8% to stake
    Traded Aug 18 Filed Aug 18
    ↗
  4. Michael J Harrington Director
    Buy
    $109K 5,000 shares at $21.82 +4% to stake
    Traded Aug 12 Filed Aug 13
    ↗
  5. Robert M VanHimbergen CFO
    Buy
    $97K 4,200 shares at $23.08 +3.2% to stake
    Traded Aug 7 Filed Aug 10
    ↗
  6. Paul Herendeen Director
    Buy
    $237K 10,000 shares at $23.69 +9.8% to stake
    Traded Aug 7 Filed Aug 10
    ↗
  7. Rajeev A. Modi See Remarks
    Buy
    $100K 4,911 shares at $20.35 +3.2% to stake
    Traded May 15 Filed May 19
    ↗
  8. Jeffrey N Simmons CEO
    Buy
    $100K 4,971 shares at $20.09 +3% to stake
    Traded May 15 Filed May 19
    ↗
  9. Lawrence Erik Kurzius Director
    Buy
    $213K 10,000 shares at $21.30 +8.2% to stake
    Traded Dec 12, 2025 Filed Dec 16, 2025
    ↗
  10. Rajeev A. Modi See Remarks
    Buy
    $96K 4,500 shares at $21.33 +3.8% to stake
    Traded Dec 11, 2025 Filed Dec 15, 2025
    ↗
  11. Robert M VanHimbergen CFO
    Buy
    $150K 6,950 shares at $21.64 +5.9% to stake
    Traded Dec 11, 2025 Filed Dec 15, 2025
    ↗
  12. Jeffrey N Simmons CEO
    Buy
    $478K 22,000 shares at $21.75 +15% to stake
    Traded Dec 11, 2025 Filed Dec 15, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 50 stock grants, 22 share withholdings for taxes, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 3 shown.

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q 10-Q FOR THE PERIOD ENDED JUNE 30, 2026 Filing Doc
SCHEDULE 13G — Filing Doc

Source: SEC EDGAR submissions, updated 11 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.